SG Americas Securities’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-58,986
| Closed | -$78K | – | 2923 |
|
|
2022
Q3 | $78K | Buy |
58,986
+153
| +0.3% | +$202 | ﹤0.01% | 2609 |
|
|
2022
Q2 | $131K | Buy |
58,833
+2,517
| +4% | +$5.6K | ﹤0.01% | 2693 |
|
|
2022
Q1 | $349K | Buy |
+56,316
| New | +$349K | ﹤0.01% | 1888 |
|
|
2021
Q4 | – | Sell |
-9,730
| Closed | -$892K | – | 3280 |
|
|
2021
Q3 | $892K | Buy |
+9,730
| New | +$892K | ﹤0.01% | 1839 |
|
|
2021
Q2 | – | Sell |
-23,254
| Closed | -$838K | – | 2787 |
|
|
2021
Q1 | $838K | Sell |
23,254
-18,832
| -45% | -$679K | ﹤0.01% | 1513 |
|
|
2020
Q4 | $1.17M | Sell |
42,086
-12,556
| -23% | -$349K | 0.01% | 1283 |
|
|
2020
Q3 | $2.73M | Buy |
54,642
+15,868
| +41% | +$793K | 0.02% | 455 |
|
|
2020
Q2 | $1.8M | Buy |
38,774
+35,096
| +954% | +$1.62M | 0.01% | 734 |
|
|
2020
Q1 | $168K | Buy |
+3,678
| New | +$168K | ﹤0.01% | 2217 |
|